Polsinelli, a nationally recognized law firm, has announced a strategic addition to its food and drug practice with the inclusion of Claire Davies as a shareholder. Davies, known for her extensive expertise in regulatory and compliance matters, will be joining the firm’s Denver office. Her role will focus on advising clients on complex issues surrounding regulatory and compliance requirements in sectors spanning biological products, pharmaceuticals, medical devices, and cellular and tissue-based products.
The firm’s decision to bring Davies on board underscores a growing emphasis on strengthening regulatory practices amid evolving challenges in the food and drug industries. Her expertise is expected to enhance the firm’s capacity to navigate the intricate landscape of FDA regulations, providing its clients with informed guidance and support.
This move was confirmed in a recent announcement by Polsinelli.
For more detailed insights, the original announcement regarding Claire Davies’ appointment can be accessed here.